Source: iQoncept / Shutterstock
Immunome (NASDAQ:IMNM) recently revealed its performance for the fourth quarter of 2023.
- Surpassing expectations, Immunome reported earnings per share of -15 cents, significantly beating the analyst estimate of -28 cents.
- The company’s revenue stood at a remarkable $3.83 million.
- This figure reflected a striking 84.83% increase over the analyst estimate of $2.07 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/imnm-stock-earnings-immunome-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
